• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过质谱法直接测定顺铂在细胞色素C上的主要结合位点。

Direct determination of the primary binding site of cisplatin on cytochrome C by mass spectrometry.

作者信息

Zhao Ting, King Fred L

机构信息

C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, West Virginia 26506-6045, USA.

出版信息

J Am Soc Mass Spectrom. 2009 Jun;20(6):1141-7. doi: 10.1016/j.jasms.2009.02.013. Epub 2009 Feb 13.

DOI:10.1016/j.jasms.2009.02.013
PMID:19286393
Abstract

Protein-cisplatin interactions lie at the heart of both the effectiveness of cisplatin as a therapeutic agent and side effects associated with cisplatin treatment. Because a greater understanding of the protein-cisplatin interactions at the molecular level can inform the design of cisplatin-like agents for future use, mass spectrometric determination of the binding site of cisplatin on a model protein, cytochrome c, was undertaken in this paper. The monoadduct cytochrome c-Pt(NH(3))(2)(H(2)O) is found to be the primary adduct produced by the cytochrome c-cisplatin interactions under native conditions. To locate the primary binding site of cisplatin, both free cytochrome c and the cytochrome c adducts underwent trypsin digestion, followed by Fourier transform mass spectrometry (FT-MS) to identify unique fragments in the adduct digest. Four such fragments were found in the adduct digest. Tandem mass spectrometry (MS/MS and MS(3) indicates that two fragments are Pt(NH(3))(2)(H(2)O) bound peptides (Gly56-Glu104 and Asn54-Glu104) with one water associated at the peptide bond Lys79-Met80, and the other two fragments are heme containing peptides (acety1-Gly1-Lys53 and acety1-Gly1-Lys55). The product-ion spectra of the four fragments reveal that Met65 is the primary binding site of cisplatin on cytochrome c.

摘要

蛋白质与顺铂的相互作用是顺铂作为治疗药物有效性及顺铂治疗相关副作用的核心所在。由于在分子水平上对蛋白质与顺铂相互作用有更深入的了解有助于设计未来使用的类顺铂药物,本文对顺铂在模型蛋白细胞色素c上的结合位点进行了质谱测定。在天然条件下,单加合物细胞色素c-Pt(NH(3))(2)(H(2)O)被发现是细胞色素c与顺铂相互作用产生的主要加合物。为了确定顺铂的主要结合位点,游离的细胞色素c和细胞色素c加合物都进行了胰蛋白酶消化,随后通过傅里叶变换质谱(FT-MS)来鉴定加合物消化产物中的独特片段。在加合物消化产物中发现了四个这样的片段。串联质谱(MS/MS和MS(3))表明,两个片段是与Pt(NH(3))(2)(H(2)O)结合的肽段(Gly56-Glu104和Asn54-Glu104),在肽键Lys79-Met80处有一个水分子相连,另外两个片段是含血红素的肽段(acety1-Gly1-Lys53和acety1-Gly1-Lys55)。这四个片段的产物离子谱显示,Met65是顺铂在细胞色素c上的主要结合位点。

相似文献

1
Direct determination of the primary binding site of cisplatin on cytochrome C by mass spectrometry.通过质谱法直接测定顺铂在细胞色素C上的主要结合位点。
J Am Soc Mass Spectrom. 2009 Jun;20(6):1141-7. doi: 10.1016/j.jasms.2009.02.013. Epub 2009 Feb 13.
2
Probing the interaction of cisplatin with cytochrome C by electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry.电喷雾电离傅里叶变换离子回旋共振质谱法研究顺铂与细胞色素 C 的相互作用。
Anal Chem. 2012 Jul 17;84(14):6206-12. doi: 10.1021/ac301122w. Epub 2012 Jun 29.
3
A mass spectrometric comparison of the interactions of cisplatin and transplatin with myoglobin.顺铂和反式铂与肌红蛋白相互作用的质谱比较。
J Inorg Biochem. 2010 Feb;104(2):186-92. doi: 10.1016/j.jinorgbio.2009.10.019. Epub 2009 Oct 29.
4
Determination of binding sites in carboplatin-bound cytochrome c using electrospray ionization mass spectrometry and tandem mass spectrometry.使用电喷雾电离质谱和串联质谱法测定卡铂结合的细胞色素c中的结合位点。
J Mass Spectrom. 2005 Aug;40(8):1005-16. doi: 10.1002/jms.875.
5
Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.用质谱技术对天然和变性泛素中顺铂结合位点进行表征。
J Biol Inorg Chem. 2011 Apr;16(4):633-9. doi: 10.1007/s00775-011-0767-x. Epub 2011 Mar 2.
6
Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites.细胞色素c对铂(IV)前药的激活作用及蛋白质结合位点的表征
Mol Pharm. 2016 Sep 6;13(9):3216-23. doi: 10.1021/acs.molpharmaceut.6b00438. Epub 2016 Aug 9.
7
Top-down characterization of proteins and drug-protein complexes using nanoelectrospray tandem mass spectrometry.使用纳米电喷雾串联质谱对蛋白质和药物-蛋白质复合物进行自上而下的表征。
Rapid Commun Mass Spectrom. 2006;20(1):48-52. doi: 10.1002/rcm.2268.
8
High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.用于研究顺铂与寡核苷酸相互作用的高分辨率质谱法。
Inorg Chem. 2008 Nov 17;47(22):10626-33. doi: 10.1021/ic801371r. Epub 2008 Oct 24.
9
The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c.
Chem Commun (Camb). 2015 Feb 14;51(13):2559-61. doi: 10.1039/c4cc09056j.
10
Shape changes induced by N-terminal platination of ubiquitin by cisplatin.顺铂诱导的泛素 N-末端铂化引起的构象变化。
J Am Soc Mass Spectrom. 2010 Jul;21(7):1097-106. doi: 10.1016/j.jasms.2010.02.012. Epub 2010 Feb 11.

引用本文的文献

1
Resistance to the platinum‑based chemotherapeutic drugs in oral cancer: Focus on the role of p22phox (Review).口腔癌对铂类化疗药物的耐药性:聚焦于p22phox的作用(综述)
Biomed Rep. 2024 Oct 3;21(6):182. doi: 10.3892/br.2024.1870. eCollection 2024 Dec.
2
Quantitative Characterization of Three Carbonic Anhydrase Inhibitors by LESA Mass Spectrometry.利用 LESA 质谱技术对三种碳酸酐酶抑制剂进行定量分析。
J Am Soc Mass Spectrom. 2022 Jul 6;33(7):1168-1175. doi: 10.1021/jasms.2c00024. Epub 2022 Jun 8.
3
Approaches to Heterogeneity in Native Mass Spectrometry.

本文引用的文献

1
Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.采用自上而下的质谱方法表征铂类抗癌药物的蛋白质结合位点。
Inorg Chem. 2008 Jan 7;47(1):17-9. doi: 10.1021/ic702236m. Epub 2007 Dec 8.
2
Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.基于一个案例研究对蛋白质铂化分子机制的见解:抗癌铂(II)亚氨基醚与马心细胞色素c的反应
Biochemistry. 2007 Oct 30;46(43):12220-30. doi: 10.1021/bi701516q. Epub 2007 Oct 9.
3
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme.
基于天然质谱的异质性方法。
Chem Rev. 2022 Apr 27;122(8):7909-7951. doi: 10.1021/acs.chemrev.1c00696. Epub 2021 Sep 1.
4
Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells.顺铂与内质网(ER)膜蛋白 p22phox 的直接结合有助于口腔鳞状细胞癌(OSCC)细胞的顺铂耐药。
Molecules. 2020 Aug 21;25(17):3815. doi: 10.3390/molecules25173815.
5
Cross-linking of the DNA repair protein O-alkylguanine DNA alkyltransferase to DNA in the presence of cisplatin.顺铂存在下 DNA 修复蛋白 O-烷基鸟嘌呤 DNA 烷基转移酶与 DNA 的交联。
DNA Repair (Amst). 2020 May;89:102840. doi: 10.1016/j.dnarep.2020.102840. Epub 2020 Mar 19.
6
Sequence-dependent attack on peptides by photoactivated platinum anticancer complexes.光活化铂抗癌配合物对肽的序列依赖性攻击。
Chem Sci. 2018 Feb 12;9(10):2733-2739. doi: 10.1039/c7sc05135b. eCollection 2018 Mar 14.
7
Interaction of classical platinum agents with the monomeric and dimeric Atox1 proteins: a molecular dynamics simulation study.经典铂类药物与单体和二聚体Atox1蛋白的相互作用:分子动力学模拟研究
Int J Mol Sci. 2013 Dec 20;15(1):75-99. doi: 10.3390/ijms15010075.
8
Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs.使用自上而下和自下而上的傅立叶变换离子回旋共振质谱法对铂类抗癌药物修饰的钙调蛋白结合位点进行作图。
Anal Chem. 2011 Dec 15;83(24):9507-15. doi: 10.1021/ac202267g. Epub 2011 Nov 18.
9
Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.顺铂与人铜伴侣蛋白 Atox1 结合并促进体外展开。
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):6951-6. doi: 10.1073/pnas.1012899108. Epub 2011 Apr 11.
10
Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.用质谱技术对天然和变性泛素中顺铂结合位点进行表征。
J Biol Inorg Chem. 2011 Apr;16(4):633-9. doi: 10.1007/s00775-011-0767-x. Epub 2011 Mar 2.
抗癌铂类药物与鸡蛋清溶菌酶加合物的电喷雾电离质谱及X射线衍射研究
Chem Commun (Camb). 2007 Jan 14(2):156-8. doi: 10.1039/b611122j. Epub 2006 Oct 26.
4
Exploring metallodrug-protein interactions by ESI mass spectrometry: the reaction of anticancer platinum drugs with horse heart cytochrome c.通过电喷雾质谱法探索金属药物与蛋白质的相互作用:抗癌铂类药物与马心细胞色素c的反应
ChemMedChem. 2006 Apr;1(4):413-7. doi: 10.1002/cmdc.200500079.
5
Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.抗肿瘤金属药物与血清蛋白的相互作用:运用现代分析方法进行表征的进展
Chem Rev. 2006 Jun;106(6):2224-48. doi: 10.1021/cr040704h.
6
Structural investigation of cisplatin-protein interactions: selective platination of His19 in a cuprozinc superoxide dismutase.
Angew Chem Int Ed Engl. 2006 Feb 13;45(8):1267-9. doi: 10.1002/anie.200502599.
7
Mapping posttranslational modifications of proteins by MS-based selective detection: application to phosphoproteomics.基于质谱的选择性检测对蛋白质翻译后修饰进行图谱分析:在磷酸化蛋白质组学中的应用。
Methods Enzymol. 2005;405:82-115. doi: 10.1016/S0076-6879(05)05005-6.
8
In-solution digestion of proteins for mass spectrometry.用于质谱分析的蛋白质溶液内消化
Methods Enzymol. 2005;405:50-65. doi: 10.1016/S0076-6879(05)05003-2.
9
Peptide sequence analysis.肽序列分析
Methods Enzymol. 2005;402:209-44. doi: 10.1016/S0076-6879(05)02007-0.
10
A mass spectrometric and molecular modelling study of cisplatin binding to transferrin.顺铂与转铁蛋白结合的质谱分析和分子模拟研究
Chembiochem. 2005 Oct;6(10):1788-95. doi: 10.1002/cbic.200500067.